Active Ingredient: ACETYLCYSTEINE LYSINE
Proprietary Name: LEGUBETI
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: EQ 500MG BASE/PACKET
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N215040
Product Number: 001
Approval Date: Feb 13, 2024
Applicant Holder Full Name: GALEPHAR PHARMACEUTICAL RESEARCH INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
